» Articles » PMID: 26687129

Stem Cell Death and Survival in Heart Regeneration and Repair

Overview
Journal Apoptosis
Publisher Springer
Date 2015 Dec 22
PMID 26687129
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular diseases are major causes of mortality and morbidity. Cardiomyocyte apoptosis disrupts cardiac function and leads to cardiac decompensation and terminal heart failure. Delineating the regulatory signaling pathways that orchestrate cell survival in the heart has significant therapeutic implications. Cardiac tissue has limited capacity to regenerate and repair. Stem cell therapy is a successful approach for repairing and regenerating ischemic cardiac tissue; however, transplanted cells display very high death percentage, a problem that affects success of tissue regeneration. Stem cells display multipotency or pluripotency and undergo self-renewal, however these events are negatively influenced by upregulation of cell death machinery that induces the significant decrease in survival and differentiation signals upon cardiovascular injury. While efforts to identify cell types and molecular pathways that promote cardiac tissue regeneration have been productive, studies that focus on blocking the extensive cell death after transplantation are limited. The control of cell death includes multiple networks rather than one crucial pathway, which underlies the challenge of identifying the interaction between various cellular and biochemical components. This review is aimed at exploiting the molecular mechanisms by which stem cells resist death signals to develop into mature and healthy cardiac cells. Specifically, we focus on a number of factors that control death and survival of stem cells upon transplantation and ultimately affect cardiac regeneration. We also discuss potential survival enhancing strategies and how they could be meaningful in the design of targeted therapies that improve cardiac function.

Citing Articles

Cardiomyopathy: pathogenesis and therapeutic interventions.

Huang S, Li J, Li Q, Wang Q, Zhou X, Chen J MedComm (2020). 2024; 5(11):e772.

PMID: 39465141 PMC: 11502724. DOI: 10.1002/mco2.772.


Genetically modified mesenchymal stromal cells: a cell-based therapy offering more efficient repair after myocardial infarction.

Xu C, Xie Y, Wang B Stem Cell Res Ther. 2024; 15(1):323.

PMID: 39334266 PMC: 11438184. DOI: 10.1186/s13287-024-03942-7.


Exosomes Derived from Mesenchymal Stem Cells: Therapeutic Opportunities for Spinal Cord Injury.

Zhang C Bull Exp Biol Med. 2024; 176(6):716-721.

PMID: 38888648 DOI: 10.1007/s10517-024-06095-y.


Cellular preconditioning and mesenchymal stem cell ferroptosis.

Zineldeen D, Mushtaq M, Haider K World J Stem Cells. 2024; 16(2):64-69.

PMID: 38455100 PMC: 10915960. DOI: 10.4252/wjsc.v16.i2.64.


Emerging Strategies and Effective Prevention Measures for Investigating the Association Between Stroke and Sudden Cardiac Fatality.

Kumar H, Jeevanandham S, Ganesh M, Sabana M, Manivasakam P Curr Cardiol Rev. 2024; 20(3):35-44.

PMID: 38310557 PMC: 11284691. DOI: 10.2174/011573403X259676231222053709.


References
1.
Henry T, Grines C, Watkins M, Dib N, Barbeau G, Moreadith R . Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials. J Am Coll Cardiol. 2007; 50(11):1038-46. DOI: 10.1016/j.jacc.2007.06.010. View

2.
Chen J, Crawford R, Chen C, Xiao Y . The key regulatory roles of the PI3K/Akt signaling pathway in the functionalities of mesenchymal stem cells and applications in tissue regeneration. Tissue Eng Part B Rev. 2013; 19(6):516-28. DOI: 10.1089/ten.TEB.2012.0672. View

3.
Sheng Z, Knowlton K, Chen J, Hoshijima M, Brown J, Chien K . Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy. J Biol Chem. 1997; 272(9):5783-91. DOI: 10.1074/jbc.272.9.5783. View

4.
Li R, Weisel R, Mickle D, Jia Z, Kim E, Sakai T . Autologous porcine heart cell transplantation improved heart function after a myocardial infarction. J Thorac Cardiovasc Surg. 1999; 119(1):62-8. DOI: 10.1016/s0022-5223(00)70218-2. View

5.
Pasha Z, Haider H, Ashraf M . Efficient non-viral reprogramming of myoblasts to stemness with a single small molecule to generate cardiac progenitor cells. PLoS One. 2011; 6(8):e23667. PMC: 3157438. DOI: 10.1371/journal.pone.0023667. View